News Column

TG THERAPEUTICS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders, Other Events

June 10, 2014

Item 5.07. Submission of Matters to a Vote of Security Holders.

TG Therapeutics, Inc. (the "Company") held its annual meeting of stockholders on Friday, June 6, 2014 at the offices of its legal counsel, Alston & Bird LLP, 90 Park Avenue, New York, New York 10016 at 10:30 a.m. Eastern Standard Time. Stockholders representing 31,304,385, or 83.20%, of the 37,624,407 shares entitled to vote were present in person or by proxy. Proxies were solicited by the Company pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. At the annual meeting, Proposals 1, 2 and 3 were approved. The proposals below are described in detail in the Company's definitive proxy statement dated April 23, 2014 for the annual meeting.

The results are as follows: Proposal 1

The following persons were nominated and elected directors:

Michael S. Weiss Neil Herskowitz Laurence N. William J. Mark Yann Echelard

Charney Kennedy Schoenebaum, MD

The shareholder voting for board members is summarized as follows:

Director Votes For Votes Withheld Abstentions Broker Non-Votes Michael S. Weiss 21,378,998 259,426 0 9,665,961

Neil Herskowitz 21,448,258 190,166 0 9,665,961 Laurence N. Charney 21,605,473 32,951 0 9,665,961

William J. Kennedy 21,605,473 32,951 0 9,665,961 Mark Schoenebaum, MD 21,595,474 42,950 0 9,665,961

Yann Echelard 21,213,595 424,829 0 9,665,961

All six directors will serve on the board of directors of the Company until the 2015 annual meeting.

Proposal 2

CohnReznick LLP was approved as the Company's independent registered public accountant for the fiscal year ending December 31, 2014.

The votes cast were as follows:

Votes For Votes Against Abstentions Broker Non-Votes 28,507,171 2,652,382 144,832 0

Proposal 3

An amendment to the Company's Certificate of Incorporation to decrease its authorized share capital by 350,000,000 shares from 500,000,000 to 150,000,000 was approved.

Votes cast were as follows:

Votes For Votes Against Abstentions Broker Non-Votes 21,583,368 25,999 29,057 9,665,961

Item 8.01. Other Events.

At its board of directors meeting held on June 6, 2014, the Company's board of directors approved the following changes to the compensation paid to non-employee directors:

Annual Retainer: Increased from $25,000 to $50,000; and

Additional Retainer for Audit Committee Chair: Increased from $5,000 to


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters